Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
MAR Marriott International posts narrow Q4 2025 EPS miss shares rise 428 percent amid positive investor sentiment NIXX Nixxy Inc shares rise 722 percent after Q3 2023 earnings outperform analyst expectations by wide margin Is MetLife MET stock trending lower Q4 2025 Profit Exceeds Views AAP Advance Auto Q4 2025 EPS outpaces estimates by 103 percent shares dip marginally on soft revenue PDF Solutions PDFS Stock Pivot Point Stuck 20260420 Is Cango CANG stock priced efficiently Cango posts 6629 negative EPS surprise far wider than estimated loss What CXApp Warr CXAIW is doing to expand margins CXAIW Q3 Earnings CXApp Warr Reports Without Revenue Data New Report Highlights AIs Expanding Role in Business Growth PFCREC Merger Gains Momentum as Board Seeks Presidential Approval Traders Anticipate USChina Tariff Truce Extension and Potential Boeing Aircraft Deal During Trumps Visit to China Westinghouse WAB Q1 2026 Earnings Beat Revenue NA EPS 271 Spyre Therapeutics SYRE Stock Down 200 Support Test at 7043 20260515 IGC Pharma IGC Delivers Q1 2026 Beat EPS 002 vs 002 Expected Soaring Gas Prices Drive Americans to Tap Emergency Savings Labours Streeting Challenges Blair Harnessing AI Through Democracy Not Markets Jim Cramer Shares Key Insight on Home Depot HD Shares Amid Housing Market Trends ByteDance May Spend Up to 89 Billion on AI Push to Cement Lead Over Chinese Rivals State Farm Faces Potential Legal Scrutiny Over Hail Damage Claim in Ohio Memory Chip Shortage Pressures Chinese Automakers From BYD to XPeng CCNEP Q1 2026 Earnings EPS Surpasses Estimates with 743 Beat CVSA Q1 2026 Earnings Strong EPS Surprise Drives Positive Stock Reaction VVV Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency SCSC Q1 2026 Earnings EPS Meets Estimates Stock Gains Slightly UTHR Q1 2026 Earnings EPS Misses Estimates Amid Disappointing Quarter Diebold Nixdorf DBD Q1 2026 Earnings EPS Beat Drives Modest Stock Upside AMSC Faces Resistance After Sharp Decline Key Levels to Watch Creative Media Community Trust CMCT Bounces 23 Key Resistance in Focus Anika Therapeutics Edges Higher as Stock Tests Key Resistance Zone Biomea Fusion BMEA Stages a Rebound Testing Key Resistance After a 365 Gain ADMA Biologics Slides 109 Key Support Levels in Focus Amid Biotech Headwinds